A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update

Published:2024-09 Issue: Volume:979 Page:176752
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Blazek Olivia^ORCID,Bakris George L.^ORCID

Publisher

Elsevier BV

Reference45 articles.

1. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis;Agarwal;Eur. Heart J.,2022

2. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats;Arai;Eur. J. Pharmacol.,2015

3. Enhanced expression of Gqalpha and PLC-beta1 proteins contributes to vascular smooth muscle cell hypertrophy in SHR: role of endogenous angiotensin II and endothelin-1;Atef;Am J Physiol Cell Physiol,2014

4. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes;Bakris;N. Engl. J. Med.,2020

5. Effect of KBP-5074 on blood pressure in advanced chronic kidney disease: results of the BLOCK-CKD study;Bakris;Hypertension,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3